Sclerostin expression and functions beyond the osteocyte

Bone. 2017 Mar:96:45-50. doi: 10.1016/j.bone.2016.11.024. Epub 2016 Nov 23.

Abstract

Sclerostin, the product of the SOST gene, is a secreted inhibitor of Wnt signaling that is produced by osteocytes to regulate bone formation. While it is often considered an osteocyte-specific protein, SOST expression has been reported in numerous other cell types, including hypertrophic chondrocytes and cementocytes. Of interest, SOST/sclerostin expression is altered in certain pathogenic conditions, including osteoarthritis and rheumatic joint disease, and it is unclear whether sclerostin plays a protective role or whether sclerostin may mediate disease pathogenesis. Therefore, as anti-sclerostin antibodies are being developed for the treatment of osteoporosis, it is important to understand the functions of sclerostin beyond the regulation of bone formation.

Keywords: Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis; Sclerostin; Wnt.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Bone Morphogenetic Proteins / metabolism*
  • Disease
  • Humans
  • Organ Specificity
  • Osteocytes / metabolism*

Substances

  • Bone Morphogenetic Proteins